Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels

References

• Friedenreich CM. Review of anthropometric factors and breast cancer risk. EurJ Cancer Prey 2001;10:15–32
   PubMed Web of Science ®Google Scholar
• McTiernan A. Review of anthropometric factors and breast cancer risk. Cancer 2000;88 (Suppl 5):1248–55
   PubMed Web of Science ®Google Scholar
• Suga K, Imai K, Eguchi H, et al. Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res 2001;92: 127–34
   PubMedGoogle Scholar
• Wynder EL, Cohen LA, Winters BL. The challenges of assessing fat intake in cancer research investigations. J Am Diet Assoc 1997;97 (Suppl 7):S5–8
   Google Scholar
• Chang S, Alderfer JR, Asmar L, et al. Inflammatory breast cancer survival: the role of obesity and meno-pausal status at diagnosis. Breast Cancer Res Treat 2001; 64:157–63
   Web of Science ®Google Scholar
• Jain M, Miller AB. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 1997;42:43–55
   PubMed Web of Science ®Google Scholar
• Honda H, Obi Y, Umekita Y, et al. Obesity affects expression of progesterone receptors and node met-astasis of mammary carcinomas in postmenopausal women without a family history. Pathol Int 1999; 49:198–202
   PubMed Web of Science ®Google Scholar
• Willett WC. Diet and breast cancer. J Intern Med 2001;249:395–411
   PubMed Web of Science ®Google Scholar
• Tagliaferri M, Cohen I, Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 2001;28:121–34
   Google Scholar
• Zamboni M, Armellini F, Harris T, etal. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997;66:111–15
   PubMed Web of Science ®Google Scholar
• Rochefort H. Estrogen-induced genes in breast cancer, and their medical importance. Bull Acad Natl Med 1999;183:955–68
   PubMed Web of Science ®Google Scholar
• Moudgil VK, Dinda S, Khattree N, et al. Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 2001;76:105–17
   PubMed Web of Science ®Google Scholar
• Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 1989;52: 703–25
   PubMed Web of Science ®Google Scholar
• Adams JB. Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat 1998;51:183–8
   PubMed Web of Science ®Google Scholar
• Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216:28–43
   PubMed Web of Science ®Google Scholar
• Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Instit 2003;95: 1218–26
   PubMed Web of Science ®Google Scholar
• Rock CL, Flatt SW, Newman V, et al. Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. J Am Diet Assoc 1999;99:1212–21
   PubMed Web of Science ®Google Scholar
• Colombel A, Charbonnel B. Weight gain and cardio-vascular risk factors in the postmenopausal women. Hum Reprod 1997;12 (Suppl 1):134–45
   PubMedGoogle Scholar
• Overlie I, Moen MH, Morkrid L, etal. The enodcrine transition around menopause - a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642–7
   PubMed Web of Science ®Google Scholar
• Casson PR, Carson SA. Androgen replacement therapy in women: myths and realities. Int J Fertil Menopausal Stud 1996;41:412–22
   PubMedGoogle Scholar
• Hunt KA, Sickles EA. Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. Am J Roentgenol 2000; 174:1251–5
   PubMed Web of Science ®Google Scholar
• Newman SC, Lees AW, Jenkins HJ. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 1997;26:484–90
   Google Scholar
• Katoh A, Watzlaf VJ, D'Amico F. An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 1994;70:928–33
   Google Scholar
• Hebert JR, Augustine A, Barone J, et al. Weight, height and body mass index in the prognosis of breast cancer: early results of a prospective study. IntJ Cancer 1988;42:315–18
   PubMed Web of Science ®Google Scholar
• Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Wom Health Gend Based Med 2001;10:463–70
   PubMedGoogle Scholar
• Guest AR, Helvie MA, Chan HP, et al. Adverse effects of increased body weight on quantitative measures of mammographic image quality. Am J Roentgenol 2000;175:805–10
   PubMed Web of Science ®Google Scholar
• Billich A, Nussbaumer P, Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 2000;73: 225–35
   Google Scholar
• Le Bail JC, Allen K, Nicolas JC, et al. Dehydro-epiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines. Anticancer Res 1998;18:1683–8
   PubMed Web of Science ®Google Scholar
• Begin D, Luthy IA, Labrie F. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol Cell Endocrinol 1988;58: 213–19
   Google Scholar
• Poortman J, Prenen JA, Schwarz F, etal. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J Clin Endocrinol Metab 1975;40:373–9
   PubMed Web of Science ®Google Scholar
• De Pergola G, Zamboni M, Sciaraffia M, et al. Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord 1996;20:1105–10
   PubMed Web of Science ®Google Scholar
• Maccario M, Mazza E, Ramunni J, et al. Relation-ships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin Endocrinol (04) 1999;50: 595–600
   Google Scholar
• Gunasegaram R, Peh KL, Loganath A, et al. Express-ion of 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro. Breast Cancer Res Treat 1998;50: 117–23
   PubMed Web of Science ®Google Scholar
• Gingras S, Cote S, Simard J. Multiple signaling pathways mediate interleukin-4—induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells. Mol Endocrinol 2000;14: 229–40
   Google Scholar